Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease

VANCOUVER, British Columbia–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative disorders, today announced positive results from its pivotal bioequivalence study with ALPHA-1062, a proprietary, delayed release oral tablet formulation in development for the treatment of mild to … [Read more…]

Trends in Drug Benefit Design Report Released by Pharmaceutical Strategies Group

Results in PSG’s latest benefit design research reveal an increased focus on member satisfaction DALLAS–(BUSINESS WIRE)–New research on the latest trends in benefit design launches today. Pharmaceutical Strategies Group (PSG), an EPIC company, developed the Trends in Drug Benefit Design Report—sponsored by Rx Savings Solutions. The proprietary research uncovers salient insights into the perceptions and … [Read more…]

Castle Adds to Evidence Supporting Its Skin Cancer Test Portfolio through Multiple Data Presentations at the SDPA Annual Summer Dermatology Conference 2022

New data from pooled analysis shows DecisionDx®-Melanoma can identify patients at a high risk of melanoma recurrence within a patient population deemed low risk (T1, ≤1mm) by traditional staging systems Survey of 400 dermatologic clinicians demonstrates how DecisionDx®-SCC results can lead to risk-aligned treatment plan changes for patients with high-risk squamous cell carcinoma Castle’s laboratory … [Read more…]

Takeda Announces Creation of One Cambridge Campus in Kendall Square to Drive Innovation Efforts

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE:TAK) today announced that it has signed a 15-year lease with BioMed Realty for approximately 600,000 square feet of research and development (R&D) and office space to be built at 585 Third Street in Kendall Square. The state-of-the-art facility will allow Takeda, the largest life sciences employer in Massachusetts, to create a … [Read more…]

Global Digital Migraine Treatment Devices Market Research Report to 2027 – Technology Advancements in the Digital Migraine Treatment Devices Presents Opportunities –

DUBLIN–(BUSINESS WIRE)–The “Digital Migraine Treatment Devices Market Research Report by Product Type, Application, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to’s offering. The Global Digital Migraine Treatment Devices Market size was estimated at USD 308.27 million in 2021, USD 344.63 million in 2022, and is projected … [Read more…]

Global Arthritis Monoclonal Antibodies Markets 2022-2026 & 2031: Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima –

DUBLIN–(BUSINESS WIRE)–The “Arthritis Monoclonal Antibodies Global Market Report 2022: By Drug, By Application, By End-Use” report has been added to’s offering. Arthritis Monoclonal Antibodies Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global arthritis monoclonal antibodies (mab’s) market. This report focuses on … [Read more…]

Heavy Metal Poisoning Drugs in Development 2022, by Stages, Target, MoA, RoA, Molecule Type and Key Players –

DUBLIN–(BUSINESS WIRE)–The “Heavy Metal Poisoning Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update” report has been added to’s offering. The pipeline guide provides comprehensive information on the therapeutics under development for Heavy Metal Poisoning (Toxicology), complete with analysis by stage of development, drug target, mechanism of action … [Read more…]

Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH

PARIS & BAGSVÆRD, Denmark–(BUSINESS WIRE)–#NAFLD—Echosens, a high-technology company offering liver diagnostic solutions, and Novo Nordisk A/S, a leading global healthcare company, today announced a partnership to advance early diagnosis of non-alcoholic steatohepatitis (NASH) and increase awareness of the disease among patients, healthcare providers and other stakeholders. NASH is a chronic metabolic liver disease that affects … [Read more…]

Battery Ventures Makes Majority Investment in Titian Software

Deal will fuel continued growth at U.K.-based, sample-management software company, which improves research processes for critical biotech, pharmaceutical and academic organizations BOSTON–(BUSINESS WIRE)–#industrialtech–Battery Ventures, a global, technology-focused investment firm, announced a significant, majority investment in Titian Software Ltd., a U.K. company that develops innovative sample-management software and related services for life-sciences laboratories. Specific terms were … [Read more…]

Congenica Appoints Robert Denison as CEO

CAMBRIDGE, England–(BUSINESS WIRE)–Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, today announces the appointment of Robert Denison as Chief Executive Officer (CEO). He will also join the Board of the company. Rob has a strong history of growing businesses ranging from start-ups through to … [Read more…]